Advancing Personalised Dosimetry Through LUTADose Lab: Building the Evidence Required to Optimise Radiopharmaceutical Therapy

• Sharing insights from the LUTADose initiative and evaluating how personalised dosimetry approaches can improve treatment planning and patient outcomes
• Understanding how patient-specific absorbed dose measurements can be leveraged to optimise efficacy while reducing unnecessary toxicity
• Exploring the role of quantitative imaging, modelling and dosimetric assessment in moving beyond standardised dosing approaches

Speakers: